Mainz Biomed NV expected to post a loss of 25 cents a share - Earnings Preview

Reuters
2024-11-08
Mainz Biomed NV <mynz.oq> expected to post a loss of 25 cents a share - Earnings Preview </mynz.oq>
  • Mainz Biomed NV MYNZ.OQ, MYNZ.O is expected to show a fall in quarterly revenue when it reports results on November 11 (estimated) for the period ending March 31 2024

  • The Mainz Hessen-based company is expected to report a 10.0% decrease in revenue to $225 thousand from $250 thousand a year ago, according to the mean estimate from 2 analysts, based on LSEG data.

  • ​LSEG's mean analyst estimate for Mainz Biomed NV is for a loss of 25 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Mainz Biomed NV is $2.00​, above​ its last closing price of $0.22. ​​​

This summary was machine generated November 8 at 15:42 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10